
Merck & Co. announced Monday that it had submitted an application with the U.S. Food and Drug Administration for emergency use approval of the first antiviral pill targeted to COVID-19. Experts say authorization of molnupiravir, at this time only for use inhigh-risk Americans, could be a major advance in the struggle against COVID-19 because a… read on > read on >